We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Mosenzon and colleagues conducted a renal analysis in 17 ...
Use of rivaroxaban (Xarelto; Bayer/Janssen) on top of dual antiplatelet therapy in patients with acute coronary syndrome is associated with a significant reduction in fatal or irreversible harmful ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results